-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HH-006 in Hepatitis D
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HH-006 in Hepatitis D report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HH-006 in Hepatitis D Drug Details: HH-006 is under development for the...
-
Product Insights
FAD-Dependent Decaprenylphosphoryl-Beta-D-Ribofuranose 2-Oxidase – Drugs In Development, 2023
Global Markets Direct’s FAD-Dependent Decaprenylphosphoryl-Beta-D-Ribofuranose 2-Oxidase provides in depth analysis on FAD-Dependent Decaprenylphosphoryl-Beta-D-Ribofuranose 2-Oxidase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in FAD-Dependent Decaprenylphosphoryl-Beta-D-Ribofuranose 2-Oxidase targeted therapeutics...
-
Product Insights
HMETC – HMETC European Research and Development (R&D) Center – Hesse
The HMETC – HMETC European Research and Development (R&D) Center – Hesse project involves the construction of the European Research and Development (R&D) Center in Rüsselsheim-Königstädten, Hesse, Germany. Equip yourself with the essential tools needed to make informed and profitable decisions with our HMETC – HMETC European Research and Development (R&D) Center – Hesse report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the...
-
Product Insights
Akeso – Shanghai Global R&D Center – Shanghai
The Akeso – Shanghai Global R&D Center – Shanghai project involves the construction of a global research and development (R&D) center at the Zhangjiang Headquarters Park in Shanghai, China. Equip yourself with the essential tools needed to make informed and profitable decisions with our Akeso – Shanghai Global R&D Center – Shanghai report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding...
-
Company Insights
New1Drop Diagnostics Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our 1Drop Diagnostics Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. 1Drop Diagnostics offers best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices. GlobalData's Medical Devices company profile report, “1Drop Diagnostics Pipeline Insight and Competitive Landscape, 2024" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and data related to: Top level information about...
-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Sector Analysis
NewAmyotrophic Lateral Sclerosis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2029
This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan and Canada) and provides an Excel-based forecast model for the Amyotrophic Lateral Sclerosis (ALS) market through 2029. The prevalence of ALS is increasing at a steady rate, in line with population growth in the 8MM, at an annual growth rate (AGR) of 0.79%.The diagnosed prevalent cases of ALS across the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Canada) are expected to increase from...
-
Product Insights
Field D Mine
The Field D Mine is a coal mine in Serbia. It is currently in operation. Empower your strategies with our Field D Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...
-
Product Insights
D-Shaft Mine
The D-Shaft Mine is a gold mine in South Africa. It is currently in operation. Empower your strategies with our D-Shaft Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Product Insights
No D-5A Mine
The No D-5A Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our No D-5A Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...